http://www.fda.gov/cder/orange/appendix_a.txt RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL I.V., METRONIDAZOLE HYDROCHLORIDE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HCL, FLAVOXATE HYDROCHLORIDE FLAXEDIL, GALLAMINE TRIETHIODIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLEXICORT, HYDROCORTISONE FLOLAN...
Welcome to Lilly UK - Gemzar (Gemcitabine Hydrochloride) Summary of Product Characteristics Click on one of the following links to go to the Electronic Medicine CompendiumGemzar Patient Information Leaflets Click on one of the following links to go to the Electronic...
Welcome to Lilly UK - Drug Name Generic Name Therapy Area Axid Nizatidine Gastrointestinal Disease Celance Pergolide mesilate Parkinson's disease Cialis Tadalafil Erectile Dysfunction Distaclor MR / Distaclor Cefaclor Infectious Diseases Evista Raloxifene Hydrochloride Osteoporosis Forsteo Teriparatide Osteoporosis Gemzar Gemcitabine Hydrochloride Cancer Humalog Human Insulin...
FDA Drug Approvals List- August 1998 Hypoestrogenism due to hypogonadism, castration, or primary ovarian failure Efficacy Supplemental New Drug Applications - Application #: 020304 Efficacy Supplement #: 004 Type: SE1 to Original New Drug Application Approval Date: 28-AUG-98 Trade Name: TRASYLOL Dosage Form: INJECTABLE Applicant: BAYER CORP Active Ingredient(s): APROTININ BOVINE OTC/RX Status: RX Efficacy Claim:...
DDPA May 1996 20-509 GEMZAR ELI LILLY GEMCITABINE HYDROCHLORIDE 02-MAY-96 (INJECTABLE) INDIANAPOLIS, IN EQ 1MG BASE/VIAL 46285 (ANTINEOPLASTIC) 20-509 GEMZAR ELI LILLY GEMCITABINE HYDROCHLORIDE 02-MAY-96 (SOLUTION) INDIANAPOLIS, IN EQ 200MG BASE/VIAL 46285 (ANTINEOPLASTIC) 20-410 GASTROMARK ADVANCED MAGNETICS FERUMOXSIL 07-MAY-96 (SUSPENSION) CAMBRIDGE, MA EQ 0...
Drug Approvals for September 1997 The development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program Original Application #: 020857 Approval Date: 26-SEP-97 Trade Name: COMBIVIR Chemical Type: 4 Therapeutic Potential: P Dosage Form: TABLET Applicant: GLAXO WELLCOME INC Active Ingredient(s): LAMIVUDINE; ZIDOVUDINE OTC/RX Status: RX Indication(s): Treatment...
Lorus Therapeutics - - - var rimPath = null; var rjsPath = null; var rPath2Root = null; function InitRelCode() { var iImg; var jImg; var tObj; if(!document.layers) { iImg = document.images['DMBImgFiles']; jImg = document.images['DMBJSCode']; tObj = jImg; } else { tObj = document.layers['DMBRI']; if(tObj) { iImg = tObj.document.images['DMBImgFiles']; jImg = tObj.document.images['DMBJSCode']; } } if(...
Gemcitabine - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Gemcitabine - [Medication] - Quest Diagnostics Patient Health Library Gemcitabine - [Medication] - Quest Diagnostics Patient Health Library Cancer, Lungs and airways, Urinary system, adult non-Hodgkin's lymphoma, antineoplastic agents, antineoplastic...
AstraZeneca and Lilly Collaborate on Clinical Trial Programmes To Study IRESSAa„¢ (ZD1839) In Combination With GemzarA® Skip to content Home Media Press releases - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 Corporate reports Facts, products, pipeline Image library Events calendar Media contacts Investors Careers Products Licensing Research Responsibility About us Contact us Home - - Media - - Press releases - -2001 - - function managePressContacts() { window.navigate("ncm.aspx?node=press");...
AstraZeneca News - press release archive - pharmaceutical news - 2001 Skip to content Home Media Press releases - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 Corporate reports Facts, products, pipeline Image library Events calendar Media contacts Investors Careers Products Licensing Research Responsibility About us Contact us Home - - Media - - Press releases - -2001 - - Press release archive 2001 28 December 2001 AstraZeneca submits clinical...
BioPortfolio Limited Datamonitor Oncology Reports 2004 Reasons to Purchase > Identify future market opportunities by examining unmet needs and how current treatment fails to improve survival for brain metastasis patients > Understand the epidemiology and current clinical treatments in brain metastasis > Plan new product development based on an understanding of physician expectation of improved survival rates and...
Charles River - Preclinical Discovery Services: Oncology com © Charles River Laboratories, 2005 Figure 1: In Vivo Tumor Growth of HT- 29 Human Colon Cancer Cells in Athymic Nude Mice Treated with Paclitaxel, Irinotecan, and Gemcitabine Available Chemotherapeutic Agents ° Cisplatin ° Paclitaxel ° Methotrexate ° 5- Fluorouracil (5- FU) ° Doxorubicin ° Irinotecan ° Mitomycin C °...
author: pclasby
subject: Charles River - Preclinical Discovery Services: Oncology
Charles River - Preclinical Discovery Services: Oncology page 2
author: pclasby
subject: Charles River - Preclinical Discovery Services: Oncology
http://www.criver.com/preclinical_services/Oncology_NudeRat_Insert_2.pdf D I S C O V E R Y Charles River Laboratories' Preclinical Services are uniquely qualified to perform a full range of Oncology Studies in nude rats.
duplicates:http://www.criver.com/migration/RM/immunodeficient/documents/Oncology_NudeRat_Insert_2.pdf
http://www.criver.com/preclinical_services/Oncology_NudeRat_Insert_2.pdf page 1
duplicates:http://www.criver.com/migration/RM/immunodeficient/documents/Oncology_NudeRat_Insert_2.pdf http://www.criver.com/products/dd/PDF/Oncology_NudeRat_Insert.pdf
BioPortfolio Limited Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged TABLE OF CONTENTS About the Oncology pharmaceutical analysis team 2 Richard Faint – Director of Oncology 2 CHAPTER 1 EXECUTIVE SUMMARY 3 Scope of the analysis 3 Datamonitor insight into the pancreatic adenocarcinoma market 4 Eli Lilly’s (Gemzar) gemcitabine remains the gold-standard treatment...
BioPortfolio Limited 63 Radioimmunoconjugates (RIC) 65 Gemzar 66 Mantle cell lymphoma (MCL) 70 Induction treatment 70 Radioimmunotherapy (RIT) 71 Maintenance treatment 72 Peripheral T-cell NHL 73 Induction treatment 73 Bioimmunotherapy 74 CHAPTER 4 PIPELINE DRUGS 76 Epratuzumab 76 Profile 76 Datamonitor comments 78 Bortezomib 80 Profile 80 Pixantrone (BBR-2778) 83 Profile 83 Genasense (oblimersen...
BioPortfolio Limited However, Datamonitor believes that this is unlikely to be the case in the European markets, where Lilly’s Gemzar (gemcitabine) and Pierre Fabre/GSK’s Navelbine (vinorelbine) will continue to dominate the NSCLC market 10 Key metrics 13 CHAPTER 2 INTRODUCTION AND SCOPE 26 Coverage of the Stakeholder Insight Survey 26 CHAPTER 3 COUNTRY TREATMENT TREES 29 US 30 Japan 35...
CRL - D& D:Nude Rat Studies - - ASK CHARLES RIVER FREQUENTLY ASKED QUESTIONS ON-LINE LITERATURE WHAT'S NEW - Discovery & Development Services Overview Oncology Models & Services • Mouse Studies • Nude Rat Studies Metabolism and Pharmacokinetics Bioanalytical Chemistry Pharmacology & Surgery General & Specialty Toxicology Pathology Services Vaccine & Vector Safety Consulting Services How to Reach Us -...
C:\@to-be archived\DDS cell line sheet 02-24-04\DDS cell line sheet 03-26-04.cdr Xenograft and Syngeneic Cancer Cell Lines Cell Line HT- 29 SW- 480 HCT- 116 HT- 1080 MDA- MB- 231 FaDu HeLa OVCAR- 3 SKOV- 3 SW- 780 PC- 3 DU- 145 A- 549 NCI- H460 A375 A- 673 CaKi- 2 MIA PaCa- 2 Panc- 1 JEG- 3 Lewis Lung B- 16- F10 AR42J Tumor Type Adenocarcinoma Adenocarcinoma Adenocarcinoma Fibrosarcoma Adenocarcinoma Squamous Cell Carcinoma Adenocarcinoma Adenocarcinoma...
author: pclasby
Welcome to Lilly UK - Gemzar Generic Name: - Gemcitabine - Legal Category: - POM Product Strengths: - 200mg, 1g - Product Forms: - Vial - Presentations: - 1g x 1 Vial 200mg x 1 Vial - - Product Codes - PIP Code - EAN Code - Licence 1g x 1 - 227 - 7531 - 5014602100933 - PL 0006/0302 200mg x 1 - 227 - 7549 - 5014602100926 - PL 0006/0301 - - --- Copyright © 2000-2001 Eli Lilly and Company...
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_%20APPROVED_AUG_1998.HTML Susp 12-813 S-043 Allergan 03-Aug-1998 PROVERA Medroxyprogesterone Acetate Tablets 11-839 S-068 Pharmacia And Upjohn 04-Aug-1998 OVCON-35 Ethinyl Estradiol/Norethindrone Tablets 18-127 S-033 Bristol-Myers Squibb 10-Aug-1998 OVCON-35 Ethinyl Estradiol/Norethindrone Tablets 17-716 S-045 Bristol-Myers Squibb 10-Aug-1998 OVCON-35 Ethinyl Estradiol/Norethindrone Tablets 17-756 S-045...
http://www.phrma.org/newmedicines/resources/2003-05-12.109.pdf page 28
http://www.criver.com/products/dd/PDF/Oncology_NudeRat_Insert.pdf D I S C O V E R Y Charles River Laboratories' Preclinical Services are uniquely qualified to perform a full range of Oncology Studies in nude rats
http://www.fda.gov/cder/foi/label/2003/20509slr013_Gemzar_lbl.pdf 1 1 2 3 GEMZAR ® 4 (GEMCITABINE HCL) 5 FOR INJECTION 6 7 DESCRIPTION 8 Gemzar ® (gemcitabine HCl) is a nucleoside analogue that exhibits antitumor activityGemcitabine Clearance and Half- Life for the "Typical" Patient 59 Age Clearance Men (L/ hr/ m 2 ) Clearance Women (L/ hr/ m 2 ) Half- Life a Men (min) Half- Life a Women (min) 29...
